
IntriCon Corporation – NASDAQ:IIN
IntriCon stock price today
IntriCon stock price monthly change
IntriCon stock price quarterly change
IntriCon stock price yearly change
IntriCon key metrics
Market Cap | N/A |
Enterprise value | 225.31M |
P/E | 226.44 |
EV/Sales | 1.78 |
EV/EBITDA | 54.38 |
Price/Sales | 1.77 |
Price/Book | 2.39 |
PEG ratio | 2.34 |
EPS | -0.15 |
Revenue | 126.49M |
EBITDA | 4.14M |
Income | -1.41M |
Revenue Q/Q | 4.06% |
Revenue Y/Y | 11.90% |
Profit margin | -1.17% |
Oper. margin | -0.62% |
Gross margin | 25.33% |
EBIT margin | -0.62% |
EBITDA margin | 3.28% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeIntriCon stock price history
IntriCon stock forecast
IntriCon financial statements
Jun 2021 | 30.21M | -1.17M | -3.9% |
---|---|---|---|
Sep 2021 | 31.05M | 337K | 1.09% |
Dec 2021 | 32.17M | 24K | 0.07% |
Mar 2022 | 33.06M | -597K | -1.81% |
2021-08-09 | 0.08 | 0.23 |
---|---|---|
2021-11-08 | 0.03 | 0.04 |
2022-02-28 | 0.01 | 0.00703 |
2022-05-17 | 0.06 | -0.07 |
Jun 2021 | 124087000 | 32.13M | 25.89% |
---|---|---|---|
Sep 2021 | 123413000 | 30.53M | 24.74% |
Dec 2021 | 122459000 | 28.70M | 23.44% |
Mar 2022 | 126511000 | 32.74M | 25.88% |
Jun 2021 | -4.52M | -1.02M | 13K |
---|---|---|---|
Sep 2021 | 1.86M | 6.02M | -997K |
Dec 2021 | -2.76M | -4.71M | 77K |
Mar 2022 | -1.65M | 1.62M | -311K |
IntriCon alternative data
Aug 2023 | 873 |
---|---|
Sep 2023 | 873 |
Oct 2023 | 873 |
Nov 2023 | 873 |
Dec 2023 | 873 |
Jan 2024 | 873 |
Feb 2024 | 873 |
Mar 2024 | 873 |
Apr 2024 | 873 |
May 2024 | 873 |
Jun 2024 | 873 |
Jul 2024 | 873 |
IntriCon other data
Period | Buy | Sel |
---|---|---|
Dec 2020 | 0 | 7500 |
Jan 2021 | 0 | 8600 |
Apr 2021 | 0 | 45704 |
Jun 2021 | 0 | 6890 |
Jul 2021 | 0 | 10690 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Option | GERACI MICHAEL officer: VP Sales.. | Option to Purchase Common Stock | 8,000 | $6.9 | $55,200 | ||
Option | GERACI MICHAEL officer: VP Sales.. | Common Stock | 8,000 | $6.9 | $55,200 | ||
Option | GIORDANO NICHOLAS A director | Option to Purchase Common Stock | 10,000 | $4.1 | $41,000 | ||
Option | GIORDANO NICHOLAS A director | Common Stock | 10,000 | $4.1 | $41,000 | ||
Option | GIORDANO NICHOLAS A director | Common Stock | 6,667 | $8.8 | $58,670 | ||
Option | GIORDANO NICHOLAS A director | Common Stock | 3,333 | $5.85 | $19,498 | ||
Option | GORDER MARK STEPHEN director | Option to Purchase Common Stock | 25,000 | $6.26 | $156,500 | ||
Option | GORDER MARK STEPHEN director | Common Stock | 25,000 | $6.26 | $156,500 | ||
Option | LONGVAL SCOTT officer: President, CEO | Option to Purchase - Common Stock | 15,000 | $6.26 | $93,900 | ||
Option | LONGVAL SCOTT officer: President, CEO | Common Stock | 15,000 | $6.26 | $93,900 |
Patent |
---|
Application Filling date: 29 Jul 2021 Issue date: 3 Feb 2022 |
Grant Filling date: 14 Oct 2019 Issue date: 7 Dec 2021 |
Grant Filling date: 19 Jul 2018 Issue date: 7 Dec 2021 |
Grant Utility: Hearing assist device fitting method, system, algorithm, software, performance testing and training Filling date: 14 Jul 2020 Issue date: 17 Aug 2021 |
Grant Filling date: 14 Oct 2019 Issue date: 23 Mar 2021 |
Grant Filling date: 16 Oct 2018 Issue date: 16 Jun 2020 |
Application Filling date: 14 Oct 2019 Issue date: 16 Apr 2020 |
Grant Filling date: 14 Dec 2018 Issue date: 14 Apr 2020 |
Application Filling date: 14 Oct 2019 Issue date: 5 Mar 2020 |
Grant Filling date: 16 May 2017 Issue date: 3 Dec 2019 |
Quarter | Transcript |
---|---|
Q3 2021 8 Nov 2021 | Q3 2021 Earnings Call Transcript |
Q2 2021 9 Aug 2021 | Q2 2021 Earnings Call Transcript |
Q1 2021 10 May 2021 | Q1 2021 Earnings Call Transcript |
Q4 2020 26 Feb 2021 | Q4 2020 Earnings Call Transcript |
Insider | Compensation |
---|---|
Mr. J. Scott Longval (1977) Pres, Chief Executive Officer & Director | $312,040 |
Mr. Michael P. Geraci (1959) Senior Vice President of Sales & Marketing | $276,980 |
Mr. Dennis L. Gonsior (1959) Senior Vice President of Operations | $259,030 |
-
What's the price of IntriCon stock today?
One share of IntriCon stock can currently be purchased for approximately $24.24.
-
When is IntriCon's next earnings date?
Unfortunately, IntriCon's (IIN) next earnings date is currently unknown.
-
Does IntriCon pay dividends?
No, IntriCon does not pay dividends.
-
What is IntriCon's stock symbol?
IntriCon Corporation is traded on the NASDAQ under the ticker symbol "IIN".
-
What is IntriCon's primary industry?
Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.
-
How do i buy shares of IntriCon?
Shares of IntriCon can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are IntriCon's key executives?
IntriCon's management team includes the following people:
- Mr. J. Scott Longval Pres, Chief Executive Officer & Director(age: 48, pay: $312,040)
- Mr. Michael P. Geraci Senior Vice President of Sales & Marketing(age: 66, pay: $276,980)
- Mr. Dennis L. Gonsior Senior Vice President of Operations(age: 66, pay: $259,030)
-
How many employees does IntriCon have?
As Jul 2024, IntriCon employs 873 workers.
-
When IntriCon went public?
IntriCon Corporation is publicly traded company for more then 45 years since IPO on 17 Mar 1980.
-
What is IntriCon's official website?
The official website for IntriCon is intricon.com.
-
Where are IntriCon's headquarters?
IntriCon is headquartered at 1260 Red Fox Road, Arden Hills, MINNESOTA.
-
How can i contact IntriCon?
IntriCon's mailing address is 1260 Red Fox Road, Arden Hills, MINNESOTA and company can be reached via phone at +1 651 636 9770.
IntriCon company profile:

IntriCon Corporation
intricon.comNASDAQ
873
Medical - Instruments & Supplies
Healthcare
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. It offers micro-miniature products, microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components, and assemblies and software solutions for medical devices, hearing healthcare, and professional audio communication devices markets. The company also provides micro coils for surgical navigation clinical applications, such as interventional pulmonology and electrophysiology; joint engineering and manufacturing services for complex medical devices, including catheters covering a range of applications for cardiology, peripheral vascular, neurology, radiology, and pulmonology; bubble sensors and flow restrictors that monitor and control the flow of fluid in an intravenous infusion system; and safety needle products for original equipment manufacturing customers. In addition, it offers professional audio headset products used for emergency response needs in the fire, law enforcement, safety, aviation, and military markets; and a line of miniature ear- and head-worn devices used by performers and support staff in the music and stage performance markets. The company sells its hearing device products, and medical and professional audio communications products directly to hearing instrument manufacturers, distributors, and partnerships; and microphone products to the radio communication and professional audio industries, as well as markets and sells hearing aid devices directly to consumers through direct mail advertising, Internet, and call center. The company was formerly known as Selas Corporation of America and changed its name to IntriCon Corporation. The company was incorporated in 1930 and is headquartered in Arden Hills, Minnesota.
Arden Hills, MINNESOTA 55112
CIK: 0000088790
ISIN: US46121H1095
CUSIP: 46121H109